PCOS Supplements: What the Evidence Actually Says

Introduction

If you have PCOS and you've spent any time researching supplements, you've likely encountered an overwhelming and often contradictory landscape. Every wellness account has a stack to recommend. Every brand has a PCOS formula. And the advice ranges from genuinely evidence-based to completely unsupported - with very little to help you tell the difference.

This article cuts through that noise.

What follows is an honest, evidence-graded guide to PCOS supplementation - organised not by what is popular, but by what the clinical research actually supports. Some of these will be familiar. Some may surprise you. And some things you have seen widely recommended will not appear here, because the evidence simply does not justify the hype.

One important framing note before we start: supplements work best as part of a broader approach that addresses the metabolic root of PCOS - insulin resistance, chronic inflammation, cortisol dysregulation, and nutritional depletion. They are not a shortcut past the dietary and lifestyle foundations. But used appropriately and targeted to your specific picture, they can meaningfully support and accelerate the work you are already doing.

Before You Supplement: Get Tested

The most common supplementation mistake in PCOS is taking a generic stack without knowing your individual status. Some supplements are broadly relevant across most PCOS presentations. Others are only meaningful if you are actually deficient - and taking them without deficiency provides no benefit and occasionally causes harm.

Before committing to a supplement protocol, the following tests are worth requesting from your GP or clinician:

• Vitamin D (25-OH vitamin D)
• Ferritin (stored iron - not just haemoglobin)
• Zinc (serum zinc)
• Fasting insulin and fasting glucose
• Full blood count
• Magnesium (less reliable in serum - red blood cell magnesium is more accurate if available)

These results allow your supplementation to be targeted rather than speculative - and they provide a baseline against which to measure improvement over time.

Tier One: Strong Evidence in PCOS

These supplements have consistent, replicated clinical evidence specifically in women with PCOS or in insulin-resistant populations. They address the core mechanisms of the condition and are appropriate to consider for most women with PCOS unless contraindicated.

Inositol (Myo-Inositol and D-Chiro-Inositol)

Inositol is arguably the most well-evidenced supplement in PCOS management, with a growing body of randomised controlled trials supporting its use.

Myo-inositol is a naturally occurring compound involved in insulin signalling - it acts as a second messenger in the insulin receptor pathway, improving the efficiency of cellular insulin response. In women with PCOS, inositol deficiency and altered inositol metabolism have been identified as contributing factors to insulin resistance.¹

Clinical trials consistently show that myo-inositol supplementation in PCOS:

• Reduces fasting insulin and improves insulin sensitivity
• Lowers free testosterone and raises SHBG
• Improves cycle regularity and ovulation rates
• Reduces androgen-related symptoms including acne and hair loss
• Supports weight management through improved insulin dynamics

Inositol is one of the few PCOS supplements that has been directly compared to metformin in clinical trials, with comparable outcomes for insulin sensitisation and ovulation in several studies - and a significantly better tolerability profile.²

Inositol takes time to produce measurable effects - typically eight to twelve weeks before hormonal and cycle changes become apparent. If you start inositol, commit to a minimum of three months before evaluating whether it is working for you. Short-term assessment is one of the most common reasons women abandon an approach that would have produced results with continued use.

Magnesium

Magnesium is involved in over 300 enzymatic processes in the body, including multiple steps in insulin signalling and glucose metabolism. Deficiency is both common and clinically significant in PCOS.

Women with insulin resistance lose more magnesium through urine than insulin-sensitive individuals - a consequence of elevated insulin driving increased renal magnesium excretion. This creates a self-reinforcing cycle: insulin resistance depletes magnesium, and magnesium deficiency worsens insulin resistance.

Clinical evidence for magnesium supplementation in PCOS and insulin-resistant populations shows:³

• Reduced fasting insulin and improved insulin sensitivity
• Lower CRP and IL-6 (reduced inflammatory load)
• Improved sleep quality and reduced cortisol reactivity
• Reduced anxiety and improved mood stability

Form matters significantly. Magnesium oxide - the cheapest and most common form in generic supplements - has poor bioavailability and is largely wasted. Magnesium glycinate or bisglycinate are the preferred forms for metabolic and nervous system support, with high absorption and good tolerability. Magnesium threonate has specific evidence for cognitive and sleep support if those are primary concerns.

Vitamin D

Vitamin D deficiency is found in a striking proportion of women with PCOS - some studies report rates above 70% - and the metabolic consequences are significant.⁴

Vitamin D receptors are present on insulin-sensitive tissues, ovarian cells, and immune cells. Deficiency impairs insulin receptor function, promotes inflammatory signalling, disrupts ovarian follicle development, and is independently associated with worsened PCOS metabolic markers.

Correcting vitamin D deficiency in women with PCOS produces measurable improvements in insulin sensitivity, inflammatory markers, testosterone levels, and cycle regularity. The key word is correcting - vitamin D supplementation in women who are not deficient does not produce the same benefits.

This is why testing first matters.

Supplementation dose should be guided by your baseline level and retested after three months.

Omega-3 Fatty Acids

Omega-3 fatty acids - specifically EPA and DHA from marine sources - are among the most robustly evidenced anti-inflammatory nutrients available, with specific clinical trial data in PCOS.

A meta-analysis of omega-3 supplementation in PCOS found significant reductions in testosterone, fasting insulin, triglycerides, and CRP - addressing androgens, insulin resistance, and inflammatory load simultaneously.⁵

As covered in PCOS and Inflammation and PCOS and Acne, the anti-inflammatory effects of omega-3s have direct downstream benefits for androgenic symptoms, ovarian function, and metabolic health.

Therapeutic dose for PCOS: 2–3g combined EPA and DHA daily. Food sources - oily fish two to three times per week - contribute meaningfully but rarely reach therapeutic levels alone. Quality matters: look for products with third-party testing for oxidation and heavy metals.

Tier Two: Good Evidence, More Context-Dependent

These supplements have meaningful clinical support, but are most appropriate in specific contexts - either where deficiency is confirmed, where a particular symptom is prominent, or as additions to a Tier One foundation.

N-Acetyl Cysteine (NAC)

NAC is a precursor to glutathione - the body's primary endogenous antioxidant - and has been studied specifically in PCOS with consistently positive results.

Multiple clinical trials show NAC supplementation in PCOS reduces fasting insulin, lowers free testosterone, raises SHBG, and improves ovulation rates.⁶ One trial directly compared NAC to metformin and found comparable insulin-sensitising effects with better tolerability.

NAC's mechanism in PCOS operates through two primary pathways: reducing oxidative stress (thereby lowering the inflammatory signalling that drives androgen production) and directly improving insulin receptor sensitivity.

It is a particularly relevant addition for women with prominent oxidative stress features - skin changes, poor recovery, significant fatigue - and for those who have not achieved adequate response from inositol alone.

Berberine

Berberine is a plant-derived compound with a substantial evidence base for insulin sensitisation - comparable in several trials to metformin, which is the most commonly prescribed pharmaceutical for insulin resistance in PCOS.⁷

It works primarily by activating AMPK - an enzyme that acts as a cellular energy sensor and improves glucose uptake in muscle cells. It also has meaningful anti-inflammatory effects and beneficial impacts on gut microbiome composition, relevant to the gut–inflammation connection discussed in PCOS and Inflammation.

Berberine is a genuinely powerful insulin-sensitising agent. For this reason, it warrants the same caution as pharmaceutical management - it should not be combined with metformin without clinical supervision, and it is not appropriate during pregnancy or breastfeeding. If you are taking any medications, check for interactions before starting berberine.

Zinc

Zinc has two specific mechanisms of relevance in PCOS: it is a natural inhibitor of 5-alpha reductase (the enzyme that converts testosterone to the more potent DHT), and it is required for healthy insulin receptor function and immune regulation.

Zinc deficiency - common in insulin-resistant individuals due to increased urinary excretion - is associated with worsened androgenic symptoms including acne and hair loss, and with impaired immune function that amplifies inflammatory load.

If testing confirms deficiency, zinc supplementation is a priority. If status is adequate, additional zinc above requirements provides limited benefit and can interfere with copper absorption at high doses.

Iron (Ferritin Correction)

As discussed in PCOS and Hair Loss, ferritin deficiency is one of the most common and most consequential nutritional issues in women with PCOS - particularly for hair follicle function, energy, and cognitive performance.

Iron supplementation should only be undertaken if ferritin is confirmed low, as iron excess is harmful and supplementing without deficiency is counterproductive. The functional target for hair and energy is ferritin ≥ 70 µg/L, which is considerably higher than the standard laboratory lower reference range.

Form matters here too: ferrous bisglycinate is significantly better tolerated than ferrous sulfate (the most commonly prescribed form) and causes substantially less gastrointestinal upset. Taking iron with vitamin C improves absorption; taking it alongside calcium or coffee reduces it.

What to Be Cautious About

Many supplements have plausible mechanisms and some supporting evidence, but the research base in PCOS specifically is less extensive. A few things that are widely recommended for PCOS but warrant more scepticism:

Generic "hormone balance" blends - proprietary formulations combining multiple herbs at undisclosed or sub-therapeutic doses. The individual ingredients may have evidence; the specific combination and dose in these products usually do not. You cannot verify what you are getting or at what amount.

High-dose single-herb products without clinical context - vitex (chasteberry) is widely recommended for cycle regulation in PCOS, but the evidence specifically in PCOS is inconsistent, and it can worsen symptoms in women with elevated LH. It is not a first-line recommendation in PCOS without clinical guidance.

Collagen supplements for hair loss - collagen supports skin and connective tissue, but there is no direct evidence for collagen supplementation reversing androgenic alopecia. Addressing the hormonal and nutritional root causes is a more evidence-based investment.

The supplement industry is largely unregulated, and the PCOS supplement market in particular is saturated with products that capitalise on the frustration and desperation that many women with this condition understandably feel. The most protective question you can ask about any supplement is: what is the specific clinical evidence for this compound, at this dose, in women with PCOS or insulin resistance? If that question cannot be clearly answered, the product does not belong in your protocol.

Building Your Protocol: A Practical Framework

Rather than taking everything at once, a tiered and sequential approach allows you to assess what is working and avoid unnecessary cost and complexity. Review and adjust - retest your key markers at three to six months. Supplement protocols should evolve as your metabolic picture improves. The goal is not to be on a permanent supplement stack - it is to address specific deficiencies and support specific mechanisms while the dietary and lifestyle foundations do the deeper work.

Introduce supplements one at a time, with at least one to two weeks between additions. This makes it possible to identify what is helping, what is causing side effects, and what is not producing results - information you lose entirely if you start five new supplements in the same week.

The Bottom Line

PCOS supplementation done well is targeted, evidence-informed, and built on a foundation of testing rather than guesswork. The supplements with the strongest evidence - inositol, magnesium, omega-3s, and vitamin D - address the core metabolic mechanisms of PCOS directly, and their effects compound over time with consistent use.

The supplements that dominate the wellness market - generic blends, underdosed herbs, and products that promise hormonal balance without specifying what that means - are rarely worth the investment.

Know your numbers. Target your gaps. Use what the evidence supports. And treat supplementation as one layer of a broader approach - not a substitute for the metabolic and dietary foundations that create the conditions for genuine, lasting change.

For the complete dietary and metabolic framework that makes supplementation most effective: Best Diet for PCOS and Insulin Resistance and the overview of how insulin resistance drives PCOS: PCOS and Insulin Resistance: What's Really Driving Your Symptoms

Want a Personalised Supplement and Nutrition Protocol for Your PCOS?

Generic supplement lists can only take you so far. In my consultations, I assess your individual metabolic picture - including the blood markers that tell us where your specific gaps and drivers are - and build a nutrition and supplementation protocol around your results.

Our Metabolic Balance® programme goes beyond supplementation to recalibrate insulin sensitivity, reduce inflammatory load, and restore hormonal balance through a personalised, blood-chemistry-based nutrition plan - addressing the root cause rather than layering supplements onto an unaddressed metabolic problem.

👉 Book a Consultation

In-clinic and remote consultations available.

Free Resource - Start Here

The 7-Day Metabolic Reset is a free, structured guide for women with PCOS and insulin resistance - covering blood sugar stabilisation, anti-inflammatory nutrition, and practical daily strategies to start shifting your metabolic environment.

👉 Download the 7-Day Metabolic Reset

References

1. Unfer V, et al. (2017). Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocrine Connections, 6(8), 647–658.
2. Nestler JE, et al. (1999). Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. New England Journal of Medicine, 340(17), 1314–1320.
3. Ghasemi Tehrani H, et al. (2014). Comparing the effects of dietary supplementation with magnesium and vitamin E on insulin resistance and hormonal profile in women with PCOS. Gynecological Endocrinology, 30(9), 669–673.
4. Wehr E, et al. (2011). Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. European Journal of Endocrinology, 164(4), 575–582.
5. Khani B, et al. (2017). Effect of omega-3 fatty acid supplementation on hormonal profile and metabolic parameters in PCOS. Journal of Obstetrics and Gynaecology, 37(7), 906–910.
6. Elnashar A, et al. (2007). N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant PCOS. Fertility and Sterility, 88(2), 406–409.
7. Wei W, et al. (2012). A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with PCOS. European Journal of Endocrinology, 166(1), 99–105.